CoChat

The hyperfunction theory: An emerging paradigm for the biology of aging

Open access
Gems, David · 2022 · Ageing Research Reviews
Cited by 125

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

The process of senescence (aging) is predominantly determined by the action of wild-type genes. For most organisms, this does not reflect any adaptive function that senescence serves, but rather evolutionary effects of declining selection against genes with deleterious effects later in life. To understand aging requires an account of how evolutionary mechanisms give rise to pathogenic gene action and late-life disease, that integrates evolutionary (ultimate) and mechanistic (proximate) causes into a single explanation. A well-supported evolutionary explanation by G.C. Williams argues that senescence can evolve due to pleiotropic effects of alleles with antagonistic effects on fitness and late-life health (antagonistic pleiotropy, AP). What has remained unclear is how gene action gives rise to late-life disease pathophysiology. One ultimate-proximate account is T.B.L. Kirkwood’s disposable soma theory. Based on the hypothesis that stochastic molecular damage causes senescence, this reasons that aging is coupled to reproductive fitness due to preferential investment of resources into reproduction, rather than somatic maintenance. An alternative and more recent ultimate-proximate theory argues that aging is largely caused by programmatic, developmental-type mechanisms. Here ideas about AP and programmatic aging are reviewed, particularly those of M.V. Blagosklonny (the hyperfunction theory) and J.P. de Magalhães (the developmental theory), and their capacity to make sense of diverse experimental findings is assessed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.arr.2021.101557

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 139

  1. Abrams, 1993, Does increased mortality favor the evolution of more rapid senescence?, Evolution, 47, 877, 10.1111/j.1558-5646.1993.tb01241.x · DOI · Paper page
  2. Austad, 2018, Is antagonistic pleiotropy ubiquitous in aging biology?, Evol. Med. Public Health, 2018, 287, 10.1093/emph/eoy033 · DOI · Paper page
  3. Austad, 2004, Is aging programed?, Aging Cell, 3, 249, 10.1111/j.1474-9728.2004.00112.x · DOI
  4. Beckman, 1998, The free radical theory of aging matures, Physiol. Rev., 78, 547, 10.1152/physrev.1998.78.2.547 · DOI · Paper page
  5. Bidder, 1932, Senescence, Br. Med. J., 2, 583, 10.1136/bmj.2.3742.583 · DOI
  6. Blagosklonny, 2003, Conceptual research and phenomenology - harmonizing slices, Cell Cycle, 2, 3, 10.4161/cc.2.1.220 · doi:10.4161/cc.2.1.220
  7. Blagosklonny, 2005, Carcinogenesis, cancer therapy and chemoprevention, Cell Death Differ., 12, 592, 10.1038/sj.cdd.4401610 · DOI
  8. Blagosklonny, 2005, How cancer could be cured by 2015, Cell Cycle, 4, 269, 10.4161/cc.4.2.1493 · DOI
  9. Blagosklonny, 2005, Molecular theory of cancer, Cancer Biol. Ther., 4, 621, 10.4161/cbt.4.6.1818 · DOI
  10. Blagosklonny, 2006, Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition, Cell Cycle, 5, 2087, 10.4161/cc.5.18.3288 · DOI · Paper page
  11. Blagosklonny, 2006, Cell senescence: hypertrophic arrest beyond the restriction point, J. Cell. Physiol., 209, 592, 10.1002/jcp.20750 · DOI · Paper page
  12. Blagosklonny, 2007, An anti-aging drug today: from senescence-promoting genes to anti-aging pill, Drug Discov. Today, 12, 218, 10.1016/j.drudis.2007.01.004 · DOI
  13. Blagosklonny, 2007, Paradoxes of aging, Cell Cycle, 6, 2997, 10.4161/cc.6.24.5124 · DOI · Paper page
  14. Blagosklonny, 2007, Program-like aging and mitochondria: instead of random damage by free radicals, J. Cell. Biochem., 102, 1389, 10.1002/jcb.21602 · DOI
  15. Blagosklonny, 2007, Research by retrieving experiments, Cell Cycle, 6, 1277, 10.4161/cc.6.11.4350 · doi:10.4161/cc.6.11.4350
  16. Blagosklonny, 2008, Aging, stem cells, and mammalian target of rapamycin: a prospect of pharmacologic rejuvenation of aging stem cells, Rejuvenation Res., 11, 801, 10.1089/rej.2008.0722 · DOI · Paper page
  17. Blagosklonny, 2008, Aging: ROS or TOR, Cell Cycle, 7, 3344, 10.4161/cc.7.21.6965 · DOI · Paper page
  18. Blagosklonny, 2009, Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration, Cell Cycle, 8, 1883, 10.4161/cc.8.12.8815 · DOI · Paper page
  19. Blagosklonny, 2009, Validation of anti-aging drugs by treating age-related diseases, Aging, 1, 281, 10.18632/aging.100034 · DOI · Paper page
  20. Blagosklonny, 2010, Metformin and sex: why suppression of aging may be harmful to young male mice, Aging, 2, 897, 10.18632/aging.100264 · DOI
  21. Blagosklonny, 2010, Rapamycin and quasi-programmed aging: four years later, Cell Cycle, 9, 1859, 10.4161/cc.9.10.11872 · DOI · Paper page
  22. Blagosklonny, 2010, Why human lifespan is rapidly increasing: solving "longevity riddle" with "revealed-slow-aging" hypothesis, Aging, 2, 177, 10.18632/aging.100139 · DOI · Paper page
  23. Blagosklonny, 2010, Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives, Aging, 2, 265, 10.18632/aging.100149 · DOI · Paper page
  24. Blagosklonny, 2010, Why the disposable soma theory cannot explain why women live longer and why we age, Aging, 2, 884, 10.18632/aging.100253 · DOI
  25. Blagosklonny, 2011, NCI’s provocative questions on cancer: some answers to ignite discussion, Oncotarget, 2, 1352, 10.18632/oncotarget.432 · DOI
  26. Blagosklonny, 2012, Answering the ultimate question "what is the proximal cause of aging?", Aging, 4, 861, 10.18632/aging.100525 · DOI · Paper page
  27. Blagosklonny, 2012, Prospective treatment of age-related diseases by slowing down aging, Am. J. Pathol., 181, 1142, 10.1016/j.ajpath.2012.06.024 · DOI
  28. Blagosklonny, 2013, Big mice die young but large animals live longer, Aging, 5, 227, 10.18632/aging.100551 · DOI · Paper page
  29. Blagosklonny, 2013, M(o)TOR of aging: MTOR as a universal molecular hypothalamus, Aging, 5, 490, 10.18632/aging.100580 · DOI
  30. Blagosklonny, 2013, MTOR-driven quasi-programmed aging as a disposable soma theory: blind watchmaker vs. intelligent designer, Cell Cycle, 12, 1842, 10.4161/cc.25062 · DOI
  31. Blagosklonny, 2013, TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists, Cell Death Dis., 4, 10.1038/cddis.2013.506 · DOI · Paper page
  32. Blagosklonny, 2014, Geroconversion: irreversible step to cellular senescence, Cell Cycle, 13, 3628, 10.4161/15384101.2014.985507 · DOI · Paper page
  33. Blagosklonny, 2014, Koschei the immortal and anti-aging drugs, Cell Death Dis., 5, 10.1038/cddis.2014.520 · DOI
  34. Blagosklonny, 2018, Does rapamycin slow down time?, Oncotarget, 9, 30210, 10.18632/oncotarget.25788 · DOI
  35. Blagosklonny, 2018, Rapamycin, proliferation and geroconversion to senescence, Cell Cycle, 17, 2655, 10.1080/15384101.2018.1554781 · DOI · Paper page
  36. Blagosklonny, 2019, Rapamycin for longevity: opinion article, Aging, 11, 8048, 10.18632/aging.102355 · DOI · Paper page
  37. Blagosklonny, 2019, Rapamycin for the aging skin, Aging, 11, 12822, 10.18632/aging.102664 · DOI
  38. Blagosklonny, 2021, Anti-aging: senolytics or gerostatics (unconventional view), Oncotarget, 12, 1821, 10.18632/oncotarget.28049 · DOI
  39. Blagosklonny, 2021, DNA- and telomere-damage does not limit lifespan: evidence from rapamycin, Aging, 13, 3167, 10.18632/aging.202674 · DOI
  40. Blagosklonny, 2002, Four birds with one stone: RAPA as potential anticancer therapy, Cancer Biol. Ther., 1, 359, 10.4161/cbt.1.4.6 · doi:10.4161/cbt.1.4.6
  41. Blagosklonny, 2009, Growth and aging: a common molecular mechanism, Aging, 1, 357, 10.18632/aging.100040 · DOI · Paper page
  42. Blagosklonny, 2002, Conceptual biology: unearthing the gems, Nature, 416, 373, 10.1038/416373a · doi:10.1038/416373a
  43. Byars, 2020, Antagonistic pleiotropy in human disease, J. Mol. Evol., 88, 12, 10.1007/s00239-019-09923-2 · DOI
  44. Calabrese, 1999, Hormesis: a highly generalizable and reproducible phenomenon with important implications for risk assessment, Risk Anal., 19, 261, 10.1111/j.1539-6924.1999.tb00404.x · DOI
  45. Carter, 2011, Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles, BMC Med. Genet., 12, 160, 10.1186/1471-2350-12-160 · DOI · Paper page
  46. Chong, 2007, Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis, BMJ, 335, 755, 10.1136/bmj.39350.500428.47 · DOI · Paper page
  47. Clancy, 2001, Extension of lifespan by loss of chico, a Drosophila insulin receptor substrate protein, Science, 292, 104, 10.1126/science.1057991 · DOI · Paper page
  48. Cole, 2017, Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions, Genome Biol., 18, 58, 10.1186/s13059-017-1185-3 · DOI · Paper page
  49. Consortium, M.M., 2021. Universal DNA methylation age across mammalian tissues. bioRxiv.
  50. De Magalhaes, 2005, Cognitive aging as an extension of brain development: a model linking learning, brain plasticity, and neurodegeneration, Mech. Ageing Dev., 126, 1026, 10.1016/j.mad.2005.04.004 · DOI
  51. Demidenko, 2008, Growth stimulation leads to cellular senescence when the cell cycle is blocked, Cell Cycle, 7, 3355, 10.4161/cc.7.21.6919 · DOI · Paper page
  52. Demidenko, 2009, At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence, Cell Cycle, 8, 1901, 10.4161/cc.8.12.8810 · DOI · Paper page
  53. Demidenko, 2009, Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence, Cell Cycle, 8, 1896, 10.4161/cc.8.12.8809 · DOI · Paper page
  54. Dilman, 1971, Age-associated elevation of hypothalamic threshold to feedback control, and its role in development, ageing, and disease, Lancet, 297, 1211, 10.1016/S0140-6736(71)91721-1 · DOI · Paper page
  55. Dilman, 1984, Three models of medicine, Med. Hypoth., 15, 185, 10.1016/0306-9877(84)90124-5 · DOI
  56. Dilman, 1986, Ontogenetic model of ageing and disease formation and mechanisms of natural selection, J. Theor. Biol., 118, 73, 10.1016/S0022-5193(86)80009-1 · DOI
  57. Dufour, 2000, A causal link between respiration and senescence in Podospora anserina, Proc. Natl. Acad. Sci. USA, 97, 4138, 10.1073/pnas.070501997 · DOI · Paper page
  58. Ezcurra, 2018, C. elegans eats its own intestine to make yolk leading to multiple senescent pathologies, Curr. Biol., 28, 2544, 10.1016/j.cub.2018.06.035 · DOI · Paper page
  59. Galimov, 2021, Death happy: adaptive death and its evolution by kin selection in organisms with colonial ecology, Philos. Trans. R. Soc. B, 376, 10.1098/rstb.2019.0730 · DOI
  60. Galimov, 2019, When and how can death be an adaptation?, Biochemistry, 84, 1433
  61. Gems, 2015, The aging-disease false dichotomy: understanding senescence as pathology, Front. Genet., 6, 212, 10.3389/fgene.2015.00212 · DOI · Paper page
  62. Gems, 2009, Antioxidant defense and aging in C. elegans: is the oxidative damage theory of aging wrong?, Cell Cycle, 8, 1681, 10.4161/cc.8.11.8595 · DOI · Paper page
  63. Gems, 2021, The hoverfly and the wasp: a critique of the hallmarks of aging as a paradigm, Ageing Res. Rev., 70, 10.1016/j.arr.2021.101407 · DOI · Paper page
  64. Gems, 2005, Broad spectrum detoxification: the major longevity assurance process regulated by insulin/IGF-1 signaling?, Mech. Ageing Dev., 126, 381, 10.1016/j.mad.2004.09.001 · DOI
  65. Gems, 2001, Insulin/IGF signalling and ageing: seeing the bigger picture, Curr. Op. Genet. Dev., 11, 287, 10.1016/S0959-437X(00)00192-1 · DOI · Paper page
  66. Gems, 2008, Stress-response hormesis and aging: “that which does not kill us makes us stronger”, Cell Metab., 7, 200, 10.1016/j.cmet.2008.01.001 · DOI · Paper page
  67. Gems, 2021, Reproductive suicide: similar mechanisms of aging in C. elegans and Pacific salmon, Front. Cell Dev. Biol., 9, 10.3389/fcell.2021.688788 · DOI
  68. Gould, 1997, The exaptive excellence of spandrels as a term and prototype, Proc. Natl. Acad. Sci. USA, 94, 10750, 10.1073/pnas.94.20.10750 · DOI · Paper page
  69. Grandison, 2009, Amino-acid imbalance explains extension of lifespan by dietary restriction in Drosophila, Nature, 462, 1061, 10.1038/nature08619 · DOI · Paper page
  70. de Grey, 2002, Time to talk SENS: critiquing the immutability of human aging, Ann. N. Y Acad. Sci., 959, 452, 10.1111/j.1749-6632.2002.tb02115.x · DOI · Paper page
  71. de la Guardia, 2016, Run-on of germline apoptosis promotes gonad senescence in C. elegans, Oncotarget, 7, 39082, 10.18632/oncotarget.9681 · DOI
  72. Hamilton, 1966, The moulding of senescence by natural selection, J. Theor. Biol., 12, 12, 10.1016/0022-5193(66)90184-6 · DOI · Paper page
  73. Hansen, 2007, Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans, Aging Cell, 6, 95, 10.1111/j.1474-9726.2006.00267.x · DOI · Paper page
  74. Harman, 1956, Aging: a theory based on free radical and radiation chemistry, J. Gerontol., 11, 298, 10.1093/geronj/11.3.298 · DOI · Paper page
  75. Hipkiss, 2007, On why decreasing protein synthesis can increase lifespan, Mech. Ageing Dev., 128, 412, 10.1016/j.mad.2007.03.002 · DOI
  76. Holliday, 1989, Food, reproduction and longevity: is the extended lifespan of calorie-restricted animals an evolutionary adaptation?, BioEssays, 10, 125, 10.1002/bies.950100408 · DOI · Paper page
  77. Holliday, 1997, Understanding ageing, Philos. Trans. R. Soc. Lond. B Biol. Sci., 52, 1793, 10.1098/rstb.1997.0163 · DOI
  78. Honda, 1999, The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans, FASEB J., 13, 1385, 10.1096/fasebj.13.11.1385 · DOI · Paper page
  79. Horvath, 2018, DNA methylation-based biomarkers and the epigenetic clock theory of ageing, Nat. Rev. Genet., 19, 371, 10.1038/s41576-018-0004-3 · DOI · Paper page
  80. Horvath, 2019, Rapamycin retards epigenetic ageing of keratinocytes independently of its effects on replicative senescence, proliferation and differentiation, Aging, 11, 3238, 10.18632/aging.101976 · DOI · Paper page
  81. Howes, 2006, The free radical fantasy: a panoply of paradoxes, Ann. N. Y Acad. Sci., 1067, 22, 10.1196/annals.1354.004 · DOI · Paper page
  82. Johnson, 1992, The search for the genetic basis of aging: the identification of gerontogenes in the nematode Caenorhabditis elegans, J. Am. Geriatr. Soc., 40, 936, 10.1111/j.1532-5415.1992.tb01993.x · DOI · Paper page
  83. Keaney, 2003, No increase in lifespan in Caenorhabditis elegans upon treatment with the superoxide dismutase mimetic EUK-8, Free Radic. Biol. Med., 34, 277, 10.1016/S0891-5849(02)01290-X · DOI
  84. Keaney, 2004, Superoxide dismutase mimetics elevate superoxide dismutase activity in vivo but do not retard aging in the nematode Caenorhabditis elegans, Free Radic. Biol. Med., 37, 239, 10.1016/j.freeradbiomed.2004.04.005 · DOI · Paper page
  85. Kenyon, 2010, The genetics of ageing, Nature, 464, 504, 10.1038/nature08980 · DOI · Paper page
  86. Kirkwood, 2010, Why women live longer. Stress alone does not explain the longevity gap, Sci. Am., 303, 34, 10.1038/scientificamerican1110-34 · doi:10.1038/scientificamerican1110-34
  87. Kirkwood, 2005, Food restriction, evolution and ageing, Mech. Ageing Dev., 126, 1011, 10.1016/j.mad.2005.03.021 · DOI
  88. Kirkwood, 1977, Evolution of ageing, Nature, 270, 301, 10.1038/270301a0 · DOI · Paper page
  89. Kirkwood, 1991, Evolution of senescence: late survival sacrificed for reproduction, Philos. Trans. R. Soc. Lond., 332, 15, 10.1098/rstb.1991.0028 · DOI · Paper page
  90. Klass, 1977, Aging in the nematode Caenorhabditis elegans: major biological and environmental factors influencing life span, Mech. Ageing Dev., 6, 413, 10.1016/0047-6374(77)90043-4 · DOI · Paper page
  91. Leontieva, 2016, Gerosuppression by pan-mTOR inhibitors, Aging, 8, 3535, 10.18632/aging.101155 · DOI
  92. Leontieva, 2012, Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging, Aging, 4, 899, 10.18632/aging.100528 · DOI · Paper page
  93. Leontieva, 2015, Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program), Oncotarget, 6, 23238, 10.18632/oncotarget.4836 · DOI · Paper page
  94. Lithgow, 2002, Stress resistance as a determinate of C. elegans lifespan, Mech. Ageing Dev., 123, 765, 10.1016/S0047-6374(01)00422-5 · DOI · Paper page
  95. Loeb, 1917, On the influence of food and temperature upon the duration of life, J. Biol. Chem., 32, 103, 10.1016/S0021-9258(18)86663-7 · DOI · Paper page
  96. Lohr, 2019, Does senescence promote fitness in Caenorhabditis elegans by causing death?, Ageing Res. Rev., 50, 58, 10.1016/j.arr.2019.01.008 · DOI
  97. Ludwig, 1980, What to expect from gerontological research?, Science, 209, 1071, 10.1126/science.209.4461.1071 · doi:10.1126/science.209.4461.1071
  98. Lui, 2010, Changes in gene expression associated with aging commonly originate during juvenile growth, Mech. Ageing Dev., 131, 641, 10.1016/j.mad.2010.08.010 · DOI
  99. Macdonald, 2018, Aberrant growth of maxillary canine teeth in male babirusa (genus Babyrousa), Comptes Rendus Biol., 341, 245, 10.1016/j.crvi.2018.04.003 · doi:10.1016/j.crvi.2018.04.003
  100. de Magalhães, 2012, Programmatic features of aging originating in development: aging mechanisms beyond molecular damage?, FASEB J., 26, 4821, 10.1096/fj.12-210872 · DOI · Paper page
  101. de Magalhães, 2005, Genomes optimize reproduction: aging as a consequence of the developmental program, Physiology, 20, 252, 10.1152/physiol.00010.2005 · DOI · Paper page
  102. Maklakov, 2019, Evolution of ageing as a tangle of trade-offs: energy versus function, Proc. Biol. Sci., 286
  103. Masoro, 1996, The evolution of the antiaging action of dietary restriction: a hypothesis, J. Gerontol. A Biol. Sci. Med. Sci., 51, B387, 10.1093/gerona/51A.6.B387 · DOI · Paper page
  104. Matsuyama, 2019, Epigenetic clock analysis of human fibroblasts in vitro: effects of hypoxia, donor age, and expression of hTERT and SV40 largeT, Aging, 11, 3012, 10.18632/aging.101955 · DOI
  105. McCay, 1934, Prolonging the life span, Sci. Mon., 39, 405
  106. Moorad, 2019, Evolutionary ecology of senescence and a reassessment of Williams' 'extrinsic mortality' hypothesis, Trends Ecol. Evol., 34, 519, 10.1016/j.tree.2019.02.006 · DOI
  107. Nacusi, 2011, Targeting 5alpha-reductase for prostate cancer prevention and treatment, Nat. Rev. Urol., 8, 378, 10.1038/nrurol.2011.67 · DOI
  108. Napalkov, 2001, The scientific career of V. M. Dil'man, Vopr. Onkol., 47, 135
  109. Northrop, 1917, The effect of prolongation of the period of growth on the total duration of life, J. Biol. Chem., 32, 123, 10.1016/S0021-9258(18)86664-9 · doi:10.1016/s0021-9258(18)86664-9
  110. Osborne, 1917, The effect of retardation of growth upon the breeding period and duration of life of rats, Science, 45, 294, 10.1126/science.45.1160.294 · DOI · Paper page
  111. Park, 2010, Longevity, aging, and caloric restriction: Clive Maine McCay and the construction of a multidisciplinary research program, Hist. Stud. Nat. Sci., 40, 79, 10.1525/hsns.2010.40.1.79 · DOI
  112. Partridge, 2002, The evolution of longevity, Curr. Biol., 12, R544, 10.1016/S0960-9822(02)01048-5 · DOI
  113. Partridge, 2002, A lethal side-effect, Nature, 418, 921, 10.1038/418921a · DOI
  114. Partridge, 2006, Beyond the evolutionary theory of ageing, from functional genomics to evo-gero, Trends Ecol. Evol., 21, 334, 10.1016/j.tree.2006.02.008 · DOI
  115. Piper, 2017, Matching dietary amino acid balance to the in silico-translated exome optimizes growth and reproduction without cost to lifespan, Cell Metab., 25, 610, 10.1016/j.cmet.2017.02.005 · DOI · Paper page
  116. Poulsen, 1999, Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance–a population-based twin study, Diabetologia, 42, 139, 10.1007/s001250051131 · DOI · Paper page
  117. Promislow, 1993, On size and survival: progress and pitfalls in the allometry of life span, J. Gerontol., 48, B115, 10.1093/geronj/48.4.B115 · DOI
  118. Radak, 2005, Exercise and hormesis: oxidative stress-related adaptation for successful aging, Biogerontology, 6, 671, 10.1007/s10522-004-7386-7 · DOI · Paper page
  119. Raj, 2020, Current perspectives on the cellular and molecular features of epigenetic ageing, Exp. Biol. Med., 245, 1532, 10.1177/1535370220918329 · DOI · Paper page
  120. Rattan, 2008, Increased molecular damage and heterogeneity as the basis of aging, Biol. Chem., 389, 267, 10.1515/BC.2008.030 · DOI · Paper page
  121. Rea, 2005, A stress-sensitive reporter predicts longevity in isogenic populations of Caenorhabditis elegans, Nat. Genet., 37, 894, 10.1038/ng1608 · DOI · Paper page
  122. Shore, 2013, A cytoprotective perspective on longevity regulation, Trends Cell Biol., 23, 409, 10.1016/j.tcb.2013.04.007 · DOI · Paper page
  123. Sohal, 1996, Oxidative stress, caloric restriction, and aging, Science, 273, 59, 10.1126/science.273.5271.59 · DOI · Paper page
  124. Strenk, 2005, The mechanism of presbyopia, Prog. Retin. Eye Res., 24, 379, 10.1016/j.preteyeres.2004.11.001 · doi:10.1016/j.preteyeres.2004.11.001
  125. Tsang, 2007, Targeting mammalian target of rapamycin (mTOR) for health and diseases, Drug Discov. Today, 12, 112, 10.1016/j.drudis.2006.12.008 · DOI · Paper page
  126. Tu, 2002, The demography of slow aging in male and female Drosophila mutant for the insulin-receptor substrate homolog chico, Aging Cell, 1, 75, 10.1046/j.1474-9728.2002.00010.x · DOI · Paper page
  127. Untergasser, 2005, Benign prostatic hyperplasia: age-related tissue-remodeling, Exp. Gerontol., 40, 121, 10.1016/j.exger.2004.12.008 · DOI · Paper page
  128. Van Raamsdonk, 2010, Reactive oxygen species and aging in Caenorhabditis elegans: causal or casual relationship?, Antioxid. Redox Signal., 13, 1911, 10.1089/ars.2010.3215 · DOI · Paper page
  129. Vanfleteren, 1993, Oxidative stress and ageing in Caenorhabditis elegans, Biochem. J., 292, 605, 10.1042/bj2920605 · DOI · Paper page
  130. Wang, H., Zhang, Z. and Gems, D., 2018a. Monsters in the uterus: teratoma‐like tumors in senescent C. elegans result from a parthenogenetic quasi‐program Aging 10, 1188–1189. · DOI
  131. Wang, 2018, A parthenogenetic quasi-program causes teratoma-like tumors during aging in wild-type C. elegans, NPJ Aging Mech. Dis., 4, 6, 10.1038/s41514-018-0025-3 · DOI
  132. Wang, 2017, Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment, Genome Biol., 18, 57, 10.1186/s13059-017-1186-2 · DOI · Paper page
  133. Warner, 2004, The future of aging interventions, J. Gerontol. A Biol. Sci. Med. Sci., 59, B692, 10.1093/gerona/59.7.B692 · DOI
  134. Waters, 2000, Life expectancy, antagonistic pleiotropy, and the testis of dogs and men, Prostate, 43, 272, 10.1002/1097-0045(20000601)43:4<272::AID-PROS6>3.0.CO;2-D · DOI
  135. Weindruch, 1982, Dietary restriction in mice beginning at 1 year of age: Effect on life span and spontaneous cancer incidence, Science, 215, 1415, 10.1126/science.7063854 · DOI · Paper page
  136. Yang, 2010, A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegans, PLoS Biol., 8, 10.1371/journal.pbio.1000556 · DOI · Paper page
  137. Zajitschek, 2019, Evolution under dietary restriction decouples survival from fecundity in Drosophila melanogaster females, J. Gerontol. A Biol. Sci. Med. Sci., 74, 1542, 10.1093/gerona/gly070 · DOI
  138. Zhao, 2017, Two forms of death in aging Caenorhabditis elegans, Nat. Commun., 8, 15458, 10.1038/ncomms15458 · DOI
  139. Zimniak, 2008, Detoxification reactions: relevance to aging, Ageing Res. Rev., 7, 281, 10.1016/j.arr.2008.04.001 · DOI

Cited by

See all 125

Metadata

Authors
Gems, D.
Venue
Ageing Research Reviews
Publisher
Elsevier BV
Published
2022-02
Volume
74
Pages
101557
ISSN
1568-1637 (ISSN-L)
OpenAlex
W4226032931
Cited by
125
References
33
FWCI
1.64
Type
journal article
Language
en
Open access
green
Funders
Wellcome Trust (215574/Z/19/Z)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The hyperfunction theory: An emerging paradigm for the biology of aging. https://app.cochat.ai/papers/10.1016/j.arr.2021.101557
The paper
Gems, D. (2022). The hyperfunction theory: An emerging paradigm for the biology of aging. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2021.101557

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.